- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07704983
Resin Infiltration Versus Microabrasion With CPP-ACP for Fluorotic White Spot Lesions
Resin Infiltration Versus Microabrasion Combined With CPP-ACP for Masking Fluorotic Anterior White Spot Lesions: A 6-Month Randomized Controlled Clinical Trial
Dental fluorosis can cause visible chalky-white spots on the front teeth. These white spot lesions may affect dental appearance even when the tooth surface is intact.
This randomized clinical trial compared two minimally invasive approaches for masking fluorotic white spot lesions on permanent anterior teeth. Eligible teeth were randomly assigned to receive either resin infiltration or enamel microabrasion followed by application of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP).
The main outcomes were the color difference between the white spot lesion and the surrounding sound enamel and the proportion of the visible tooth surface occupied by the lesion. These outcomes were evaluated from standardized clinical photographs before treatment, after treatment, and during follow-up through 6 months.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This was a prospective, controlled, two-arm randomized clinical trial conducted at the Dental Clinic of the University of Medicine and Pharmacy Hospital, Hue University, Vietnam, between June 2023 and June 2025. Patients with fluorotic white spot lesions on permanent anterior teeth were enrolled. Eligible lesions were shallow, chalky-white enamel opacities confined to the outer enamel and clinically consistent with dental fluorosis.
Randomization was performed at the tooth level. A total of 60 eligible teeth were allocated in a 1:1 ratio to one of two treatment groups: resin infiltration or enamel microabrasion followed by CPP-ACP application. Allocation was concealed using sequentially numbered, opaque, sealed envelopes. All procedures were performed by one operator under standardized clinical conditions.
In the resin-infiltration group, the lesion surface was treated with 15% hydrochloric acid, rinsed and dried, followed by ethanol application. A low-viscosity resin infiltrant was then applied and light-cured according to the study protocol.
In the microabrasion plus CPP-ACP group, the labial enamel surface was treated with a hydrochloric-acid and silicon-carbide microabrasion material using repeated polishing cycles. CPP-ACP paste was then applied to the treated surface for 5 minutes.
Two co-primary outcomes were evaluated from standardized clinical photographs: the color difference between the lesion and adjacent sound enamel, expressed as ΔE in the CIELab* color space, and the lesion-area ratio, expressed as the percentage of the visible labial tooth surface occupied by the lesion. Images were obtained under reproducible lighting, magnification, camera-positioning, and patient-positioning conditions.
Color measurements were obtained from sampled points within the lesion and adjacent sound enamel. Lesion area and total labial-surface area were outlined and measured using image-analysis software. Outcome assessments were performed by an independent examiner who was blinded to treatment allocation using coded image files. Measurements were obtained before treatment and at prespecified post-treatment and follow-up assessments through 6 months.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Huế, Viêt Nam, 530000
- Faculty of Odonto-Stomatology, University of Medicine and Pharmacy, Hue University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Patients presenting with fluorotic white spot lesions on permanent anterior teeth.
- Shallow fluorotic white spot lesions confined to the outer enamel.
- Chalky-white lesions with a clear border from adjacent sound enamel.
- Lesions appearing bright on oblique visual inspection and mildly dim under diagnostic transillumination.
- Clinical diagnosis of dental fluorosis based on the characteristic bilateral, symmetrical, and diffuse distribution of enamel opacities.
- Willingness to participate in the study and comply with treatment and follow-up visits.
Exclusion Criteria:
- Deep subsurface enamel lesions.
- Lesions consistent with molar-incisor hypomineralization.
- Lesions with yellow or brown discoloration.
- Known allergy or hypersensitivity to ICON, Opalustre, Tooth Mousse, or their components.
- Inability to tolerate rubber-dam isolation.
- Poor oral hygiene.
- Inability or unwillingness to attend the scheduled follow-up assessments.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Resin Infiltration
Eligible fluorotic white spot lesions were treated with resin infiltration using the ICON Vestibular Kit.
After rubber-dam isolation, 15% hydrochloric acid was applied for 120 seconds, rinsed for 30 seconds, and air-dried.
Ethanol was applied for 30 seconds, and the etching step was repeated if needed.
The resin infiltrant was then applied, excess material was removed, and the surface was light-cured according to the study protocol.
|
After tooth cleaning and rubber-dam isolation, 15% hydrochloric acid was applied to the fluorotic white spot lesion for 120 seconds, rinsed for 30 seconds, and air-dried.
Ethanol was applied for 30 seconds to assess lesion masking, and the etching step was repeated if the lesion remained visible.
A low-viscosity resin infiltrant was applied for 180 seconds, excess material was removed, and the surface was light-cured for 40 seconds.
A second application was performed for 60 seconds and light-cured for an additional 40 seconds.
|
|
Comparateur actif: Microabrasion Plus CPP-ACP
Eligible fluorotic white spot lesions were treated with enamel microabrasion followed by CPP-ACP application.
Opalustre containing 6.6% hydrochloric acid and silicon carbide particles was applied to the labial enamel surface and polished with a rubber cup at approximately 500 rpm for 60 seconds.
The procedure was repeated for five cycles, followed by application of CPP-ACP gel for 5 minutes.
|
After tooth cleaning and rubber-dam isolation, an enamel microabrasion material containing 6.6% hydrochloric acid and silicon carbide particles was applied to the labial enamel surface and polished with a rubber cup at approximately 500 rpm for 60 seconds.
The surface was rinsed, and the procedure was repeated for five cycles.
CPP-ACP paste was then applied to the treated enamel surface for 5 minutes.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
CIELAB Color Difference Between the Fluorotic Lesion and Adjacent Sound Enamel
Délai: At baseline and four post-treatment assessments through 6 months (T0-T4)
|
The color difference between the fluorotic white spot lesion and adjacent sound enamel was measured from standardized clinical photographs in the CIELab* color space.
Mean L*, a*, and b* values were obtained from three points within the lesion and three points on adjacent sound enamel located 2 mm from the lesion margin.
Color difference was calculated as ΔE = [(ΔL*)² + (Δa*)² + (Δb*)²]¹ᐟ².
Lower ΔE values indicate better color matching and lesion masking.
A ΔE value below 3.7 was considered not clinically perceptible to the naked eye.
|
At baseline and four post-treatment assessments through 6 months (T0-T4)
|
|
Fluorotic Lesion-Area Ratio on the Labial Tooth Surface
Délai: At baseline and four post-treatment assessments through 6 months (T0-T4)
|
The fluorotic white spot lesion and the visible labial tooth surface were outlined on standardized clinical photographs and measured using ImageJ.
The lesion-area ratio was calculated as R (%) = (lesion area / total visible labial surface area) × 100.
Scores range from 0% to 100%, with lower values indicating a smaller visible lesion area and better lesion masking.
|
At baseline and four post-treatment assessments through 6 months (T0-T4)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Van Nhat Thang Le, DDS PhD, Faculty of Odonto-Stomatology, University of Medicine and Pharmacy, Hue University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Hypominéralisation de l'émail dentaire
- Défauts de développement de l'émail
- Maladies stomatognathiques
- Maladies dentaires
- Anomalies du système stomatognathique
- Anomalies congénitales
- Anomalies dentaires
- Maladies et anomalies congénitales, héréditaires et néonatales
- Fluorose dentaire
- Dentisterie
- Esthétique, dentaire
- nanocomplexe de phosphopeptide de caséine et de phosphate de calcium amorphe
- Microabrasion de l'émail
Autres numéros d'identification d'étude
- H2023/124
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .